Phase 3 Sputnik V Vaccine Trials: Hope, Challenges, and Global Opportunities
The global race to develop an effective COVID-19 vaccine gained momentum when Russia announced the registration of Sputnik V, developed by the Gamaleya Research Institute. The announcement...